STAGE IV PANCREATIC CANCER
Clinical trials for STAGE IV PANCREATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IV PANCREATIC CANCER trials appear
Sign up with your email to follow new studies for STAGE IV PANCREATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise against Hard-to-Treat cancers
Disease control OngoingThis study tests a drug called ceralasertib, alone or with olaparib or durvalumab, in people with advanced solid tumors like kidney, bladder, pancreatic, and endometrial cancers. The goal is to see if these combinations can shrink tumors by blocking enzymes that help cancer grow.…
Matched conditions: STAGE IV PANCREATIC CANCER
Phase: PHASE2 • Sponsor: Rahul Aggarwal • Aim: Disease control
Last updated Jun 17, 2026 02:16 UTC
-
New drug combo shows promise in Hard-to-Treat cancers
Disease control OngoingThis early-phase study tests a new drug (sEphB4-HSA) combined with standard chemotherapy in people with advanced or metastatic solid tumors, including head and neck, pancreatic, lung, and gallbladder cancers. The goal is to find the best dose and check for side effects. About 61 …
Matched conditions: STAGE IV PANCREATIC CANCER
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 03, 2026 12:03 UTC